Impact of NQO1 C609T Polymorphism on The Outcome of Childhood Acute Lymphoblastic Leukemia from Zagazig University Hospital; Egypt | ||||
| The Egyptian Journal of Hospital Medicine | ||||
| Article 50, Volume 87, Issue 1, April 2022, Page 1293-1296 PDF (539.75 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejhm.2022.223321 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Mohamed Eissa  ; Amal Ahmed Zidan; Ola Aly Hossein; Alaa A. Omran
| ||||
| KSA, Abha, 61412, P.O. Box 641 | ||||
| Abstract | ||||
| Background: The NAD (P) H: quinone oxidoreductase (NQO1) C609T polymorphism has been widely thought to be associated with the risk of acute leukemia. Objective: This case-control study aimed to assess the impact of NQO1 C609T gene polymorphism in childhood acute lymphoblastic leukemia (ALL). Patients and Method: The study was carried out on one hundred de novo ALL children and one hundred apparently healthy children. Routine genotyping of NQO1C609T gene polymorphism by PCR-RFLP was done for all subjects. Results: No statistically significant difference was observed between the patient group and control group as regards wild and polymorphic genotypes. However, there was a significant difference between ALL patients with wild and polymorphic genotypes regarding their immunophenotyping diagnosis (P=0.02) and FAB classification (P=0.01). There was also a significant difference between ALL patients with wild and polymorphic genotypes regarding their response to treatment. The complete remission in the wild genotype (CC) was 69.2% while in polymorphic genotypes (TT & CT) was 29.4% (P<0.05). Conclusion: The polymorphic genotype forms of the NQO1 C609T (CT and TT) are associated with decreased response to treatment. | ||||
| Keywords | ||||
| NQO1; TT; CT; ALL; genotypes | ||||
|
Statistics Article View: 210 PDF Download: 265 |
||||
